Literature DB >> 24029186

Pediatric Inflammatory Diseases. Part IV: Miscellaneous, Reye, PRES, Sarcoidosis.

M Gallucci1, J D Smith, N Limbucci, A Rossi, P Demaerel, T Krings, A D'Amico, C Micheli.   

Abstract

Some rare neurological diseases affecting children have no well defined etiology and pathogenetic mechanisms. In this article diseases like Reye syndrome, Behçet disease, pediatric neurosarcoidosis, Posterior Reversible Encephalopathy Syndrome are described. Some of the main neuroradiological differential aspects are also critically considered. Reye syndrome is characterized by symmetric thalamic, white matter and basal ganglia lesions, in children with recent history of salycilates or immunosuppressive drugs intake. The most typical MRI feature of neurosarcoidosis is basilar meningeal thickening and enhancement with intraparenchymal enhancing nodules and white matter focal abnormalities. The classical distribution of lesions helps differential diagnosis with infectious meningoencephalitis. Differential diagnosis with relapsing-remitting multiple sclerosis his helped by the evidence of meningeal abnormalities. Neuro-Behçet is characterized by mesodiencephalic lesions in children with encephalopathy and coexistence of oral and genital ulcers and ocular abnormalities. PRES can be differentiated from vasculitis for the typical posterior white matter involvement and the different clinical features.

Entities:  

Year:  2012        PMID: 24029186     DOI: 10.1177/197140091202500612

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  2 in total

1.  3-Hydroxy-3-methylglutaric aciduria with bilateral basal ganglia lesion: A case report.

Authors:  Xiaosheng Hao; Jiangtao Wang; Songyan Liu; Yinbo Chen; Yan Zhang; Yunpeng Hao
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

Review 2.  Rare causes of emesis.

Authors:  Stefan L Popa; Giuseppe Chiarioni; Liliana David; George I Golea; Dan L Dumitrascu
Journal:  Med Pharm Rep       Date:  2020-04-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.